Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Equity Ratio (2016 - 2023)

Historic Equity Ratio for Aptevo Therapeutics (APVO) over the last 9 years, with Q3 2023 value amounting to 0.54.

  • Aptevo Therapeutics' Equity Ratio rose 909.24% to 0.54 in Q3 2023 from the same period last year, while for Sep 2023 it was 0.54, marking a year-over-year increase of 909.24%. This contributed to the annual value of 0.53 for FY2022, which is 234522.44% up from last year.
  • Per Aptevo Therapeutics' latest filing, its Equity Ratio stood at 0.54 for Q3 2023, which was up 909.24% from 0.56 recorded in Q2 2023.
  • In the past 5 years, Aptevo Therapeutics' Equity Ratio ranged from a high of 0.67 in Q1 2023 and a low of 0.13 during Q1 2022
  • For the 5-year period, Aptevo Therapeutics' Equity Ratio averaged around 0.35, with its median value being 0.4 (2019).
  • Examining YoY changes over the last 5 years, Aptevo Therapeutics' Equity Ratio showed a top increase of 234522.44% in 2022 and a maximum decrease of 18523.64% in 2022.
  • Quarter analysis of 5 years shows Aptevo Therapeutics' Equity Ratio stood at 0.22 in 2019, then surged by 39.76% to 0.31 in 2020, then crashed by 93.07% to 0.02 in 2021, then skyrocketed by 2345.22% to 0.53 in 2022, then grew by 3.27% to 0.54 in 2023.
  • Its Equity Ratio stands at 0.54 for Q3 2023, versus 0.56 for Q2 2023 and 0.67 for Q1 2023.